Speed to Market: Why 3rd Party Pharma Manufacturing Beats Building a Plant

The strongest argument for third-party manufacturing is not cost. It is time. A brand owner with no plant can go from decision to stock in about six weeks. The same person building a facility is two to three years away from selling a single strip — and by then the market he was chasing has moved.

This page is about speed. For the money, read the cost case. For the mechanics, read how the process works.

Six weeks versus two years

Building a compliant plant means land, construction, clean rooms, HVAC, water systems, equipment, validation, licensing and an inspection. Two to three years is normal, and none of it earns anything.

Third-party manufacturing skips every step, because somebody already did them. Pick a formulation from an approved catalogue, submit your documents, sign, approve artwork, and the batch is manufactured and dispatched. Four to six weeks from confirmed order is typical.

You are not renting a factory. You are renting the two years someone else already spent.

Why the approved catalogue is the real accelerator

This is the part people underestimate. A manufacturer's existing formulations are already developed, already approved and already validated on their line. Picking from that list means the regulatory work is done — and it is not your regulatory work, it is theirs.

Develop something genuinely new and you are back to a development cycle, stability data and approvals. Most brands do not need that. They need a good combination, a good name, and to be in front of a doctor next month.

Where the time actually goes

Four to six weeks assumes two things you control, and one you do not.

• Artwork approval — you. This is the single most common cause of a late batch, and it is almost always sitting on the brand owner's desk. Approve fast.
• Trademark filing — you. No manufacturer will safely print an uncleared brand name. Start this before artwork, not after.
• API procurement — them. If the raw material needs sourcing, the clock extends. Ask at the quotation stage, not in week five.

Speed to fail, which matters more than it sounds

A new molecule at a contract manufacturer costs you one batch. If it does not move, you stop ordering and it is over. The same product at your own plant costs a validated line, a stability programme, and floor space it occupies whether it sells or not.

Cheap failure is what lets a brand try more things. That is not a consolation prize — it is how ranges get built.

The speed limit nobody mentions

You cannot outrun the certificate. A plant certified for tablets, capsules, external preparations and oral liquids cannot make your injectable next month, or ever. Beta-lactams need physically segregated premises — that is regulation, not scheduling. Ophthalmics and injectables need sterile lines.

So confirm the site is certified for your dosage form before you build a launch plan around a date. That is the one delay no amount of urgency fixes, and it is the one people discover last. Here are the other nine mistakes.

Who manufactures for Vibcare

Vibcare Pharma is a PCD pharma franchise company. It does not manufacture. Manufacturing is done by Vibcare Healthcare Private Limited — a separate company under the same ownership, with its own plant, licences and website.

The site: Khasra No. 6/2/2, Kota Road, Dabkori, Panchkula 134103, Haryana. WHO-GMP certified by the State Drugs Controller-cum-Licensing Authority, FDA Haryana. Site Certificate No. 1/182-1Drug-I-2024, issued 24 October 2024. Licences MLF252023HR000004 and MLF282023HR000005, valid to 7 May 2028. 100,000 sq ft clean room, 750+ drug approvals — which is exactly the point of this page: those approvals already exist, and you do not have to wait for them.

Certified for four dosage forms: tablets, capsules and external preparations — all non beta-lactam — and oral liquids. It does not make beta-lactam antibiotics, ophthalmics, injectables, softgels, IV liquids, respules, DPI, nasal sprays, protein powders and sachets, or ayurvedic products, because it is not certified for them. Better you know that today than in week five of a launch plan.

Want to sell next month with no manufacturer at all? A PCD pharma franchise gives you an existing range in a monopoly territory, from ₹25,000 — no artwork, no trademark, no batch. Here is the difference.

Frequently asked questions

How fast can you launch a product with third-party manufacturing?

Four to six weeks from a confirmed order is typical, if you pick from the manufacturer's approved formulations and approve artwork quickly. Building your own compliant plant instead takes two to three years before you sell a single strip, because construction, validation, licensing and inspection all come first.

What delays a third-party manufacturing batch?

Artwork approval is the most common cause, and it usually sits with the brand owner. Trademark filing is the second — no manufacturer will safely print an uncleared brand name. Third is API procurement, which is the manufacturer's side; ask about it at the quotation stage rather than week five.

Why is third-party manufacturing faster than building a plant?

Because the two years of construction, validation, licensing and inspection have already been spent by someone else, and their formulations are already approved. You are renting completed regulatory work, not just machinery. That is the actual product being sold.

Can a manufacturer make any dosage form quickly if I pay more?

No. A site certificate lists exactly which dosage forms a plant may produce. Beta-lactams require physically segregated premises by regulation; ophthalmics and injectables need sterile lines. No urgency or budget changes that. Confirm the certificate covers your dosage form before you set a launch date.